Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Slawson, A. Shaughnessy (2005)
Teaching Evidence-Based Medicine: Should We Be Teaching Information Management Instead?Academic Medicine, 80
E. Antman, Joseph Lau, B. Kupelnick, F. Mosteller, T. Chalmers (1992)
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.JAMA, 268 2
J. Staffa, Jennie Chang, L. Green (2002)
Cerivastatin and reports of fatal rhabdomyolysis.The New England journal of medicine, 346 7
P. Jüni, L. Nartey, S. Reichenbach, R. Sterchi, P. Dieppe, M. Egger (2004)
Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 364
S. Majumdar, F. McAlister, S. Soumerai (2003)
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States.The American journal of medicine, 115 6
N. Col, T. Mclaughlin, S. Soumerai, D. Hosmer, J. Yarzebski, J. Gurwitz, J. Gore, R. Goldberg (1996)
The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study.Archives of internal medicine, 156 1
J. Ely, J. Osheroff, M. Ebell, G. Bergus, B. Levy, M. Chambliss, E. Evans (1999)
Analysis of questions asked by family doctors regarding patient careBMJ, 319
K. Lasser, P. Allen, S. Woolhandler, D. Himmelstein, S. Wolfe, D. Bor (2002)
Timing of new black box warnings and withdrawals for prescription medications.JAMA, 287 17
Michael Green, Marc Ciampi, Peter Ellis (2000)
Residents' medical information needs in clinic: are they being met?The American journal of medicine, 109 3
A. Shaughnessy, D. Slawson (1999)
Are we providing doctors with the training and tools for lifelong learning?BMJ, 319
H. Fineberg (1987)
Clinical evaluation: how does it influence medical practice?Bulletin du cancer, 74 3
AbstractThis case study examined the recent withdrawal of valdecoxib to determine the timeliness of updates in commonly used information sources used by healthcare professionals. The method included assembling a purposive sample of 15 drug reference and warning systems that were then systematically monitored for several months after the withdrawal of valdecoxib to determine the time to update this information. These information sources were classified and described qualitatively. A time to diffusion curve was plotted and the average number of days to report the drug withdrawal or update reference databases was calculated. Only 2 of 15 information systems reported the drug withdrawal on the actual date of the FDA announcement. Institutional electronic textbooks took an average of 109.8 days (±14 days) to report the withdrawal. In addition, one pharma-sponsored dissemination source (Peerview Press) had not updated their information as of this publication.
Journal of the American Medical Informatics Association – Oxford University Press
Published: Jul 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.